# Acute Otitis Media

Acute otitis media requires confirmation of middle-ear effusion with compatible tympanic-membrane inflammation, not symptoms or erythema alone. Management hinges on analgesia, selective antibiotic use, reassessment of nonresponse, and recognition of uncommon suppurative or intracranial complications.

**Clinical question:** How should clinicians confirm acute otitis media and select analgesia, antibiotics, follow-up, and referral?

Updated: 2026-08-21T01:24:15.501695+00:00

## What matters in practice
- Do not diagnose AOM unless assessment supports middle-ear effusion; pneumatic otoscopy is the most reliable bedside method for evaluating tympanic-membrane mobility, with tympanometry as an adjunct. [17][18][21]
- Bulging, opacified tympanic membrane with reduced light reflex is a high-value examination pattern; tympanic-membrane erythema alone is insufficiently specific. [4][23]
- Pain and fever management are required components of care; antibiotic decisions should be selective and informed by diagnostic certainty, illness severity, age, and ability to ensure follow-up. [6][17][18]
- For established pediatric AOM in U.S. practice, high-dose amoxicillin is the usual first-line antibiotic; use an agent with additional beta-lactamase coverage when amoxicillin is not appropriate. Specific dosing and duration require current guideline or product-label verification because they are not supplied in the available excerpts. [17][18]
- Recurrent AOM is conventionally defined as at least 3 episodes in 6 months or at least 4 in 12 months with 1 in the preceding 6 months; tympanostomy tubes do not automatically outperform medical management for every child meeting this definition. [5]
- Postauricular swelling or tenderness, facial weakness, meningeal symptoms, neurologic findings, or suspected intracranial extension warrants urgent specialty and hospital evaluation. [24]

## Confirm middle-ear effusion before labeling AOM

Symptoms establish suspicion; middle-ear findings determine diagnostic confidence.

AOM is a clinical diagnosis supported by history and otoscopy, but it should not be diagnosed when pneumatic otoscopy and tympanometry do not indicate middle-ear effusion. AOM commonly follows a viral respiratory illness, which can create nonspecific otalgia, fever, and tympanic-membrane erythema without bacterial middle-ear infection. [4][17][18]

Conventional otoscopy may show an opacified, bulging tympanic membrane with an attenuated light reflex; membrane color can vary from white or yellow to pink or red. The clinically useful discriminator is evidence of effusion and impaired mobility rather than color alone. [4][21][23]

Pneumatic otoscopy evaluates membrane excursion under pressure and is more reliable than nonpneumatic otoscopy for detecting middle-ear effusion. Tympanometry can support the assessment when pneumatic otoscopy is unavailable or uncertain. Combining pneumatic otoscopy and tympanometry has been reported to increase sensitivity and specificity to greater than 90% in one study, although performance depends on technique and the reference standard. [18][21]
- Use pneumatic otoscopy when feasible: absent or markedly reduced tympanic-membrane mobility supports middle-ear effusion. [18][21]
- Use tympanometry as an adjunct for equivocal examinations or limited visualization; a flat tracing supports effusion in the appropriate clinical setting. [23]
- Do not equate persistent effusion without acute symptoms with AOM; this pattern is more consistent with otitis media with effusion. [16][20]

*Bedside interpretation of common middle-ear findings. [4][17][18][21][23]*

| Finding | Interpretation | Next clinical action |
| --- | --- | --- |
| Bulging, opacified tympanic membrane with attenuated light reflex [4] | Strongly supports an acute inflammatory middle-ear process when symptoms are compatible. [4][23] | Assess effusion/mobility, pain severity, illness severity, and follow-up reliability before deciding on antibiotics. [17][18] |
| Reduced or absent mobility on pneumatic otoscopy [18][21] | Supports middle-ear effusion. [21] | Integrate with acute symptoms and inflammatory otoscopic findings; do not use symptoms alone. [17][18] |
| Flat tympanogram [23] | Supports middle-ear effusion but does not independently distinguish AOM from OME. [16][20][23] | Correlate with acute symptoms and otoscopy; consider hearing evaluation when effusion persists or affects function. [23] |
| Erythema without documented effusion [4][17] | Nonspecific; may occur with crying, fever, or viral illness. [4][17] | Reassess with pneumatic otoscopy or tympanometry rather than prescribing for presumed AOM. [17][18][21] |

## Prioritize analgesia and use antibiotics selectively

Diagnostic certainty and clinical risk should drive antimicrobial exposure.

Pain and fever treatment should be part of management for every child with AOM. Guidelines internationally emphasize accurate diagnosis, adequate analgesia, and selective rather than routine antibiotic prescribing; nevertheless, antibiotic prescribing remains common in U.S. practice. [6][17]

The available sources identify high-dose amoxicillin as the U.S. first-line antibiotic for established AOM, particularly in children younger than 2 years. When amoxicillin is unsuitable, an antibiotic with additional beta-lactamase coverage should be used; amoxicillin-clavulanate is FDA-approved for acute otitis media. The supplied excerpts do not provide validated pediatric dosing, duration, allergy pathways, or renal-adjustment instructions, so these should be checked against current AAP guidance and FDA labeling at the point of prescribing. [1][17][18]

Observation with a mechanism for prompt reassessment is a stewardship strategy used in some settings, with antibiotics reserved for persistent or worsening symptoms. This approach reflects differing guideline interpretations and risk tolerance rather than an absence of benefit from antibiotics in selected patients. [6][17][18]
- Treat pain and fever regardless of whether an antibiotic is prescribed. [17]
- Use amoxicillin as first-line therapy for an established diagnosis when no source-supported reason exists to select broader beta-lactamase coverage. [17][18]
- Use amoxicillin-clavulanate or another agent with additional beta-lactamase coverage when indicated; verify formulation-specific dosing from current labeling or guidelines. [1][17]
- If observing, ensure that the family can recognize worsening illness and access reassessment promptly; the supplied sources do not specify a U.S. observation interval. [17][18]

### Treatment failure and persistent symptoms

Persistent symptoms or recurrent episodes after treatment should prompt diagnostic reassessment, including whether the initial diagnosis represented AOM rather than isolated effusion. Microbiologic persistence after antimicrobial therapy can reflect pathogens resistant to the administered regimen. [8][17]

Tympanocentesis may be relevant in selected recurrent or treatment-failure situations, but the supplied evidence does not define routine indications, technique, or culture-directed treatment thresholds. [7][8]
- Re-examine the tympanic membrane and document effusion status before escalating therapy. [17][18]
- Consider specialist input when recurrent disease, persistent otorrhea, tympanic-membrane perforation, or repeated antimicrobial exposure complicates management. [5][24]

*Antimicrobial decision framework supported by available excerpts. [1][6][17][18]*

| Clinical situation | Evidence-supported approach | Important limitation |
| --- | --- | --- |
| Established uncomplicated AOM | Provide analgesia; high-dose amoxicillin is described as U.S. first-line therapy. [17][18] | Specific dose and treatment duration are not available in the supplied excerpts. [17][18] |
| Need for broader beta-lactamase coverage | Use an antibiotic with additional beta-lactamase coverage; amoxicillin-clavulanate is FDA-approved for AOM. [1][17] | The excerpts do not specify selection criteria, formulation, or dose. [1][17] |
| Diagnostic uncertainty or lower-risk presentation with reliable follow-up | Selective antibiotic prescribing and observation for persistence or worsening are guideline-consistent strategies in some settings. [6][17][18] | The available sources do not provide U.S. age- and severity-specific observation criteria. [17][18] |
| Persistent or recurrent symptoms after therapy | Reassess diagnosis and consider resistant or persistent pathogens; selected cases may warrant specialist-directed evaluation. [7][8] | No source-supported escalation regimen is available in the excerpts. [7][8] |

## Define recurrent AOM precisely before considering tubes

Frequency alone does not establish that tympanostomy will improve outcomes.

Recurrent AOM is conventionally defined as at least 3 episodes within 6 months or at least 4 episodes within 12 months, with at least 1 episode during the preceding 6 months. It is the principal indication for tympanostomy-tube placement. [5]

In a randomized comparison of tympanostomy tubes versus medical management for recurrent AOM, treatment failure incorporated recurrence frequency, prolonged systemic antimicrobial treatment, persistent otorrhea, effusion, tympanic-membrane perforation, AOM-related hospitalization, and anesthesia-related adverse events. This composite highlights that tube decisions should weigh episode burden alongside otorrhea, persistent middle-ear disease, antibiotic exposure, and procedural risk. [5]

Before referral, verify that prior episodes met AOM criteria rather than being recurrent viral illness or OME. Persistent effusion is evaluated with otoscopy and tympanometry; age-appropriate audiometry and tympanometry are used to assess hearing when OME is a concern. [16][20][23]
- Document episode dates, laterality, otoscopic evidence of effusion, treatments, and interval recovery before classifying recurrent AOM. [5][17]
- Discuss procedural tradeoffs, including otorrhea, persistent effusion or perforation, and anesthesia-related adverse events considered in the recurrent-AOM trial. [5]
- Assess hearing when persistent effusion or functional hearing concern is present; audiometry and tympanometry are appropriate tools. [23]

*When recurrent AOM should trigger a more structured evaluation. [5][16][20][23]*

| Trigger | Clinical implication | Evaluation or action |
| --- | --- | --- |
| At least 3 episodes in 6 months or at least 4 in 12 months, including 1 in the prior 6 months [5] | Meets the conventional recurrent-AOM definition. [5] | Confirm episode quality and discuss ENT referral and medical versus procedural management. [5] |
| Persistent effusion between apparent infections [16][20] | May represent OME rather than ongoing acute infection. [16][20] | Assess with pneumatic otoscopy and/or tympanometry; consider audiometry for hearing assessment. [23] |
| Persistent otorrhea, perforation, prolonged systemic antibiotic exposure, or AOM-related hospitalization [5] | Indicates a more complicated disease course. [5] | Escalate evaluation and consider specialty-directed management. [5][24] |

## Recognize complications requiring urgent escalation

Most cases are uncomplicated; focal complications change the site and urgency of care.

Reported AOM complications include otitis media with effusion, tympanic-membrane perforation, and rarely mastoiditis. More severe complications described in clinical reviews include labyrinthitis, petrositis, meningitis, and brain abscess. [4][17][18]

Urgently refer or send for hospital evaluation when there is postauricular swelling or tenderness, facial nerve paralysis, fever with stiff neck, or concern for neurologic involvement. These findings may indicate mastoid, intratemporal, or intracranial complications and require resources for otoscopic, neurologic, and potentially surgical evaluation. [24]
- Postauricular tenderness or swelling: evaluate urgently for mastoid complication. [24]
- Facial weakness: urgent referral for possible facial nerve involvement. [24]
- Fever with stiff neck or neurologic symptoms: urgent hospital assessment for possible intracranial disease. [24]
- Persistent otorrhea or tympanic-membrane perforation: reassess disease course and obtain specialty input when persistent or complicated. [5][24]

*Red flags in AOM requiring urgent reassessment or referral. [24]*

| Finding | Potential concern | Immediate action |
| --- | --- | --- |
| Tender postauricular swelling [24] | Mastoid or subperiosteal complication. [24] | Urgent specialty or hospital evaluation. [24] |
| Facial nerve paralysis [24] | Intratemporal complication. [24] | Urgent referral. [24] |
| Fever with stiff neck or neurologic abnormalities [24] | Meningitis or other intracranial complication. [24] | Immediate hospital evaluation and treatment pathway. [24] |

## Common questions

### Is a red tympanic membrane sufficient to diagnose AOM?

No. AOM should not be diagnosed without evidence of middle-ear effusion on pneumatic otoscopy or tympanometry. Tympanic-membrane color is variable and must be interpreted with bulging, opacity, mobility, and acute symptoms. [4][17][18][21]

### When is tympanometry useful in suspected AOM?

Use it to support detection of middle-ear effusion when pneumatic otoscopy is unavailable, technically limited, or equivocal. A flat tympanogram supports effusion but does not by itself distinguish AOM from OME. [16][20][21][23]

### What is first-line antibiotic therapy for established pediatric AOM?

The supplied U.S.-oriented sources identify high-dose amoxicillin as first-line therapy for established AOM. Amoxicillin-clavulanate is FDA-approved for AOM and provides additional beta-lactamase coverage when needed; verify current dosing and duration from guidelines or labeling. [1][17][18]

### What defines recurrent AOM for tympanostomy consideration?

The conventional definition is at least 3 episodes in 6 months or at least 4 in 12 months, with at least 1 episode in the preceding 6 months. Confirm that documented episodes met AOM criteria before referral. [5][17]

### Which AOM findings require emergency evaluation?

Postauricular swelling or tenderness, facial paralysis, fever with stiff neck, or neurologic findings require urgent evaluation for mastoid, intratemporal, or intracranial complications. [24]

## References
1. NDA 50-755 Augmentin DS for AOM due to DRSP — www.accessdata.fda.gov — https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/50755_Augmentin_medr_P2.pdf
2. NDA 50-755 Augmentin ES for AOM due to penicillin resistant ... — www.accessdata.fda.gov — https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/50755_Augmentin_medr_P1.pdf
3. Clinical practice guidelines for acute otitis media in children — bmjopen.bmj.com — https://bmjopen.bmj.com/content/10/5/e035343
4. Acute otitis media - Symptoms, diagnosis and treatment | BMJ Best Practice US — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-us/39
5. Tympanostomy Tubes or Medical Management for ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa2027278
6. Impact of acute otitis media clinical practice guidelines on antibiotic and analgesic prescriptions: a systematic review | Archives of Disease in Childhood — adc.bmj.com — https://adc.bmj.com/content/103/6/597
7. Tympanocentesis for the Management of Acute Otitis ... — jamanetwork.com — https://jamanetwork.com/journals/jamapediatrics/fullarticle/485827
8. Microbiologic Characteristics of Persistent Otitis Media — jamanetwork.com — https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/221524
9. Effect of Antimicrobial Treatment of Acute Otitis Media on ... — jamanetwork.com — https://jamanetwork.com/journals/jamapediatrics/fullarticle/1867334
10. Intradiscal pharmacokinetics of oral antibiotics to treat Chronic Lower Back Pain | npj Antimicrobials and Resistance — www.nature.com — https://www.nature.com/articles/s44259-023-00002-7
11. Modelling impacts of paediatric amoxicillin shortage management on pneumococcal resistance and invasive disease in Europe — www.nature.com — https://www.nature.com/articles/s41467-026-72777-y
12. The Diagnosis and Management of Acute Otitis Media — publications.aap.org — https://publications.aap.org/aapbooks/book/757/chapter/14094105/The-Diagnosis-and-Management-of-Acute-Otitis-Media
13. Diagnosis and Management of Acute Otitis Media | Pediatrics — publications.aap.org — https://publications.aap.org/pediatrics/article/113/5/1451/66681/Diagnosis-and-Management-of-Acute-Otitis-Media
14. Clinical Practice Guidelines | American Academy of ... — publications.aap.org — https://publications.aap.org/collection/523/Clinical-Practice-Guidelines
15. Evidence Assessment of Management of Acute Otitis Media — publications.aap.org — https://publications.aap.org/pediatrics/article/108/2/248/63688/Evidence-Assessment-of-Management-of-Acute-Otitis
16. Antibiotics for otitis media with effusion (OME) in children - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10591283
17. Acute Otitis Media - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK470332
18. Acute Otitis Media - PubMed — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/29262176
19. Antibiotics for acute otitis media in children - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7043305
20. Antibiotics for otitis media with effusion in children - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7117560
21. New Approaches and Technologies to Improve Accuracy of Acute Otitis Media Diagnosis — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC8700495
22. Otoscopic and tympanometric findings in acute otitis media ... — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/15545858
23. Otitis Media With Effusion - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK538293
24. Chronic suppurative otitis media — iris.who.int — https://iris.who.int/server/api/core/bitstreams/615a1da5-acad-4e93-97eb-a0f45e28c9c2/content

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.